echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Pharmaceutical Marketing > Expert: The Omicron strains currently circulating in China are mainly BA.5.2 and BF.7

    Expert: The Omicron strains currently circulating in China are mainly BA.5.2 and BF.7

    • Last Update: 2023-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The joint prevention and control mechanism of the State Council held a press conference
    on the 9th on the relevant situation of the tenth edition of the diagnosis and treatment plan.
    Wang Guiqiang, director of the Department of Infectious Diseases of Peking University First Hospital, pointed out at the meeting that at present, the Omicron strain circulating in our country is mainly BA.
    5.
    2 and BF.
    7
    .
     
    At the meeting, a reporter asked: It has been ten months since the tenth version of the diagnosis and treatment plan, that is, the ninth version of the diagnosis and treatment plan, in this process, what changes have occurred in the understanding of the pathogenic mechanism of the new coronavirus, especially the Omicron variant?
     
    In this regard, Wang Guiqiang responded that with the epidemic of the Omicron strain, he has been paying attention to the pathogenic characteristics of the Omicron strain, including the pathogenic and epidemiological clinical characteristics
    .
    After infection with the Omicron strain, the virulence is reduced, the infectivity is significantly increased, and overall, compared with the Delta strain and the original strain, its pathogenicity is significantly reduced
    .
    For the current Omicron strain infection, it is still necessary to strengthen symptomatic, supportive and respiratory therapy, because if there is a severe case after Omicron strain infection, pneumonia and corresponding treatment
    are required.
    The Omicron strains currently circulating in our country are mainly BA.
    5.
    2 and BF.
    7
    .
     
    He introduced that the clinical manifestations of the Omicron strain are mainly fever, cough, fatigue, etc.
    , and individual patients will have pneumonia
    .
    However, the overall incidence of pneumonia and the Delta strain ratio were significantly reduced
    .
    Nevertheless, it is still necessary to emphasize the early diagnosis and treatment of pneumonia, especially for the elderly with underlying diseases, including immunocompromised people, and more active early monitoring and follow-up, timely treatment of disease changes, including early oxygen therapy, early antiviral therapy, etc
    .
     
    He pointed out that it is also very important that although the pathogenicity of the Omicron strain has declined, the elderly who have not been vaccinated are still at high risk of severe disease, so it is still emphasized that the elderly should be vaccinated, including the second booster immunization problem, hoping to effectively reduce the harm of the Omicron strain and reduce the mortality rate
    through such a series of measures.
    For the Omicron strain, although its virulence is declining, it is necessary to continue to pay attention to its further changes, including new mutations, potential risks, etc.
    , and optimize the diagnosis and treatment plan accordingly according to the characteristics of the strain
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.